ASH 43rd (2001)

Title Content type
Outcome of 21 Patients Undergoing Unrelated Bone Marrow Transplant for Hematologic Malignancies at a Single Institution. (click for details)
Procalcitonin (PCT): A New Marker for Diagnosis of Bacterial and Fungal Infections in Allo and Autotransplanted Pediatric Patients. (click for details)
Long-Term antifungal Prophylaxis in Allogeneic Bone Marrow Transplant Patients: A Multicenter, Randomized Trial of Intravenous/Oral Itraconazole Versus Intravenous/Oral Fluconazole (click for details)
Non-Myeloablative Transplants Using Cyclophosphamide (CY) and Fluadarabine (FL) with G-CSF Stimulated Bone Marrow. (click for details)
Intermittent Intermediate Dose Arabinosilcytosine (ID Ara-C) Preceded by a Fludarabine (FAMP) Minimum Effective Dose and All-Trans Retinoic Acid (ATRA) in Relapsed or Resistant Acute Myeloid Leukaemia (AML). (click for details)
Feasibility of Administering High-Dose Melphalan (HDM) with Autotransplantation in Myeloma Patients on Dialysis. (click for details)
In - Vivo / Ex - Vivo T - Cell Depleted Peripheral Blood Progenitor Cell Transplants : A Single Center Experience of 160 Consecutive Cases Using Three Methodes of T Cell Depletion. (click for details)
100 mg/m2 Melphalan and Repeated Infusions of G-CSF-Mobilized Allogeneic Blood Stem Cells (Microallograft) as Therapy of High-risk Myeloma Relapsing after 1-2 Previous Autografts: High Complete Response Rates in Association with Chronic Graft-Versus-Ho (click for details)
Allogeneic Blood Stem Cell Transplantation after Dose Reduced Conditioning without ATG in Patients with Severe Aplastic Anemia. (click for details)
Fludarabine with Cyclophosphamide and Mitoxantrone (FCM) in Resistant or Relapsed Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study. (click for details)

Pages

Subscribe to ASH 43rd (2001)